LSTA Lisata Therapeutics Inc
9,335
$2.26
$0.01
(0.44%)
| Watchers | 9,335 |
| 52-Wk Low | $1.95 |
| 52-Wk High | $4.53 |
| Market Cap | $18.34M |
| Volume (M) | 12,606.00 |
| 52-Wk High | $4.53 |
| 52-Wk Low | $1.95 |
Lisata Therapeutics to Present at NobleCon19 Investor ConferenceGlobe Newswire • 7 days ago
BASKING RIDGE, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Share to Feed
BASKING RIDGE, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Lisata Therapeutics, Inc. (NASDAQ:LSTA Free Report) Brookline Capital Management issued their Q1 2024 earnings per share estimates for shares of Lisata Therapeutics in a research...
Lisata Therapeutics, Inc. (LSTA) Q3 2023 Earnings Call Transcript...
Significant clinical progress achieved in studies evaluating LSTA1 including first patients treated in BOLSTER (3 solid tumor basket trial) and continued rapid enrollment in ASCEND Orphan drug...
BASKING RIDGE, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Phase 2a double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 in combination with standard-of-care versus standard-of-care alone in subjects with advanced solid tumors...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
BASKING RIDGE, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Shares of Lisata Therapeutics, Inc. (NASDAQ:LSTA Get Free Report) traded down 2.8% during trading on Tuesday . The stock traded as low as $2.05 and last traded at $2.07. 16,128 shares were...
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
Latest LSTA News
Lisata Therapeutics to Present at NobleCon19 Investor Conference
Globe Newswire • 7 days ago
Lisata Therapeutics Announces Participation in Upcoming Conferences in November
Globe Newswire • 26 days ago
Brokers Issue Forecasts for Lisata Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:LSTA)
Zolmax • 29 days ago